U.S. Compounding Pharmacies Market - Industry Dynamics, Market Size, and Opportunity Forecast to 2035

U.S. Compounding Pharmacies Market: By Facility Type (503A Compounding Pharmacies, 503B Outsourcing Facilities); Compounding Type (Sterile Compounding, Non-Sterile Compounding); Dosage Form (Oral Formulations, Topical Formulations, Injectable Formulations, Ophthalmic Formulations, Nasal Formulations, Suppositories, Other Customized Formulations); Therapeutic Application (Hormone Replacement Therapy (HRT), Pain Management, Dermatology, Veterinary Medicine, Pediatrics, Oncology Supportive Care, Dentistry, Nutritional & Wellness Therapies, Other Specialized Therapies); End User (Individual Patients, Hospitals & Health Systems, Physician Offices & Clinics, Ambulatory Surgical Centers, Veterinary Clinics, Long-Term Care Facilities); Distribution Channel (Direct Pharmacy Dispensing, Healthcare Provider Dispensing, Mail-Order Compounding Pharmacies); Region—Market Size, Industry Dynamics, Opportunity Analysis and Forecast for 2026–2035

U.S. compounding pharmacies market size was valued at USD 6.50 billion in 2025 and is projected to hit the market valuation of USD 11.63 billion by 2035 at a CAGR of 5.99% during the forecast period 2026–2035. Read More

We Are Trusted By These Great Companies!

• Last Updated: 31-May-2026  |  Format:  |  Report ID: AA05261806